The Canadian journal of cardiology · 2025
Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Scott Monte, Kyriakopoulos Christos P, Sheffield Eric, Krauspe Ethan, Sideris Konstantinos, Taleb Iosif, Maneta Eleni, Tseliou Eleni, Selko Sean, Hamouche Rana, Aadland Jake, Carter Spencer J, Jones Tara L, Ou Zhining, Presson Angela P, Selzman Craig H, Tonna Joseph E, Hanff Thomas C, Drakos Stavros G
Аннотация
BACKGROUND: In 2019, the Society for Cardiovascular Angiography and Interventions (SCAI) proposed an algorithm to assess cardiogenic shock (CS) severity, known as SCAI classification. In 2022, the Cardiogenic Shock Working Group (CSWG) modified the original classification using specific parameters to better define hypotension and hypoperfusion with the goal to further refine stratification.
METHODS: Consecutive patients with CS who were managed at a quaternary academic medical centre from May 2015 to December 2021 were evaluated (N = 1162). Our study cohort comprised patients who developed CS after admission. In-hospital mortality per SCAI stage at shock onset was assessed. The percentages of temporary mechanical circulatory support use per SCAI stage at shock onset was also reported. In our study, we included intra-aortic balloon pump, percutaneous ventricular assist device, and venoarterial extracorporeal membrane oxygenation.
RESULTS: Our study cohort comprised 742 patients with a median age of 62.0 (interquartile range, 51-72) years, mostly men (66%). Etiology of CS included 25% acute myocardial infarction and 75% non-acute myocardial infarction. In-hospital mortality per CS severity stage using the SCAI-CSWG classification was 14.30% for stage B, 20.90% for stage C, 32.70% for stage D, and 44.80% for stage E, whereas temporary mechanical circulatory support use was greatest in SCAI stage E.
CONCLUSIONS: We identified a direct relationship of in-hospital mortality per CS severity stage using the SCAI-CSWG classification in the overall cohort. These findings require further validation in prospective studies.
METHODS: Consecutive patients with CS who were managed at a quaternary academic medical centre from May 2015 to December 2021 were evaluated (N = 1162). Our study cohort comprised patients who developed CS after admission. In-hospital mortality per SCAI stage at shock onset was assessed. The percentages of temporary mechanical circulatory support use per SCAI stage at shock onset was also reported. In our study, we included intra-aortic balloon pump, percutaneous ventricular assist device, and venoarterial extracorporeal membrane oxygenation.
RESULTS: Our study cohort comprised 742 patients with a median age of 62.0 (interquartile range, 51-72) years, mostly men (66%). Etiology of CS included 25% acute myocardial infarction and 75% non-acute myocardial infarction. In-hospital mortality per CS severity stage using the SCAI-CSWG classification was 14.30% for stage B, 20.90% for stage C, 32.70% for stage D, and 44.80% for stage E, whereas temporary mechanical circulatory support use was greatest in SCAI stage E.
CONCLUSIONS: We identified a direct relationship of in-hospital mortality per CS severity stage using the SCAI-CSWG classification in the overall cohort. These findings require further validation in prospective studies.